Taneva S G, Stewart J, Taylor L, Keough K M
Department of Biochemistry, Memorial University of Newfoundland, St. John's, Newfoundland, A1B 3X9, Canada.
Biochim Biophys Acta. 1998 Mar 6;1370(1):138-50. doi: 10.1016/s0005-2736(97)00257-5.
Two methods were employed for preparation of lipid extracts from porcine lung surfactant. Pulmonary surfactant proteins SP-B and SP-C were isolated from the extracts using gel-exclusion chromatography on LH-60 with chloroform:methanol acidified with hydrochloric acid. Monolayers of pure SP-B or SP-C isolated from butanol lipid extracts spread at the air-water interface showed larger molecular areas than those determined in films of SP-B or SP-C isolated from chloroform surfactant extracts. Aqueous dispersions of dipalmitoylphosphatidylcholine (DPPC) supplemented with 2.5 and 5.0 wt% of SP-B or SP-C obtained from butanol extracts adsorbed faster to the air-water interface than their counterparts reconstituted with proteins isolated from chloroform extracts. Surface pressure-area characteristics of spread monolayers of DPPC plus SP-B or SP-C did not depend on the method of isolation of the proteins. The diagrams of the mean molecular areas vs. composition for the monolayers of DPPC plus SP-B or SP-C showed positive deviations from the additivity rule, independently of the procedure used for preparation of lipid extract surfactant. Matrix-assisted laser desorption/ionization spectrometry of the proteins isolated from different extraction solvents was consistent with some differences in the chemical compositions of SP-Bs. Butylation of SP-B during extraction of surfactant pellet with butanol may account for the differences observed in the molecular masses of SP-Bs isolated by the two different extraction protocols. The study suggests that the method of purification of SP-B and SP-C may modify their ability to enhance the adsorption rates of DPPC/protein mixtures, and this may be relevant to the formulation of protein-supplemented lipids for exogenous treatment of pulmonary surfactant insufficiency.
采用两种方法从猪肺表面活性剂中制备脂质提取物。使用LH - 60凝胶排阻色谱法,以用盐酸酸化的氯仿:甲醇从提取物中分离肺表面活性蛋白SP - B和SP - C。从丁醇脂质提取物中分离出的纯SP - B或SP - C在空气 - 水界面铺展的单层显示出比从氯仿表面活性剂提取物中分离出的SP - B或SP - C膜中测定的分子面积更大。补充有2.5 wt%和5.0 wt%从丁醇提取物中获得的SP - B或SP - C的二棕榈酰磷脂酰胆碱(DPPC)水分散体比用从氯仿提取物中分离的蛋白质重构的对应物更快地吸附到空气 - 水界面。DPPC加SP - B或SP - C铺展单层的表面压力 - 面积特性不取决于蛋白质的分离方法。DPPC加SP - B或SP - C单层的平均分子面积与组成关系图显示出与加和规则的正偏差,与用于制备脂质提取物表面活性剂的程序无关。从不同提取溶剂中分离出的蛋白质的基质辅助激光解吸/电离光谱与SP - Bs的化学组成存在一些差异一致。在用丁醇提取表面活性剂沉淀过程中SP - B的丁基化可能解释了通过两种不同提取方案分离的SP - Bs分子量中观察到的差异。该研究表明,SP - B和SP - C的纯化方法可能会改变它们增强DPPC/蛋白质混合物吸附速率的能力,这可能与用于肺表面活性剂不足的外源治疗的蛋白质补充脂质的配方有关。